Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in oscc

ABSTRACT Studies have found that circRNA in exosomes is associated with oral squamous cell carcinoma (OSCC) progression. In this study, we examined the expression of circ_0000199 in

circulating exosomes from patients with OSCC and its role in the evaluation of relapse and prognosis. Real‐time quantitative reverse transcription–polymerase chain reaction was performed to

assess circ_0000199 expression in circulating exosomes from 108 patients with OSCC and 50 healthy people. Gain- and loss-functional experiments were performed to assess the role of

circ_0000199 on cell proliferation and apoptosis in OSCC cells. Our results showed that the high level of circ_0000199 in circulating exosomes was significantly associated with betel quid

chewing, tumor size, lymphatic metastasis, and TNM stage in patients with OSCC. In addition, the patients with high exosomal circ_0000199 had higher tumor recurrence rate and higher

mortality rate than the patients with low exosomal circ_0000199. Overexpression of circ_0000199 promoted, while knockdown of circ_0000199 inhibited OSCC cell growth. Bioinformatics analysis

predicted that circ_0000199 interacted with miR-145-5p and miR-29b-3p simultaneously, which were involved in multiple tumor‐related signaling pathways. In conclusion, upregulation of

circ_0000199 in circulating exosomes from patients with OSCC is positively associated with poor survival outcome. Circulating exosomal circ_0000199 can be used as a biomarker and potential

therapeutic target for OSCC. SIMILAR CONTENT BEING VIEWED BY OTHERS TUMOR-DERIVED EXOSOMAL CIRCPSMA1 FACILITATES THE TUMORIGENESIS, METASTASIS, AND MIGRATION IN TRIPLE-NEGATIVE BREAST CANCER

(TNBC) THROUGH MIR-637/AKT1/Β-CATENIN (CYCLIN D1) AXIS Article Open access 28 April 2021 MIR-451A WAS SELECTIVELY SORTED INTO EXOSOMES AND PROMOTED THE PROGRESSION OF ESOPHAGEAL SQUAMOUS

CELL CARCINOMA THROUGH CAB39 Article 22 April 2024 EXOSOME-TRANSMITTED CIRCCOG2 PROMOTES COLORECTAL CANCER PROGRESSION VIA MIR-1305/TGF-Β2/SMAD3 PATHWAY Article Open access 11 October 2021

INTRODUCTION Oral squamous cell carcinoma (OSCC) is one of the most common malignant tumors in the world, accounting for 3% of malignant tumors1. Although the treatment of OSCC has made

breakthroughs in the past decades, the 5-year mortality rate is still less than 50%2. Early diagnosis and early treatment are the keys to improve the survival rate of patients with OSCC.

Exosomes have phospholipid bilayer membrane with the markers TSG101 and CD63. The size of exosomes ranges from 30 to 100 nm. These vesicles exist in almost all body fluids of the human body,

including blood, serum, saliva, cerebrospinal fluid, and urine3. Exosomes contain various substances, such as proteins, DNA, microRNA (miRNA), circular RNA (circRNA). These molecules can be

transported to regulate the signaling pathways of the recipient cells4. CircRNAs are covalently formed from the ends of a single RNA molecule, without 5′ and 3′ ribonucleotide end, and

circRNAs are expressed abundantly, conserved and stably in cells with temporal and spatial specificity5. CircRNAs can bind to miRNAs to inhibit their functions. Therefore, circRNA is also

called miRNA sponge. With the continuous understanding of circRNA, researchers have found that circRNAs are widely involved in the occurrence and development of physiology and disease as

well as tumors6. As a new type of regulatory endogenous RNA, circRNAs are expected to become a tumor diagnostic marker and therapeutic target due to its characteristics such as stability,

conservation, and tissue-specific expression7. For example, circRNA_100290 acts as a sponge for the miR-29 family, and activates CDK6 in oral cancer8. CircDOCK1 regulates BIRC3 expression

and participates in the process of OSCC apoptosis9. Studies have found that the level of circRNA in exosomes is closely related to oral cancer10. Has_circ_0000199 (circ_0000199) is a

recently newly identified circular RNA, located at chr1: 243708811–243736350, derived from back splicing of exons 8–11 of AKT3. Circ_0000199 has been reported to be downregulated in clear

cell renal cell carcinoma and glioblastoma, but upregulated in cisplatin-resistant gastric cancer tissues11,12,13, suggesting that circ_0000199 is tissue-specific. This study focused on the

expression of circ_0000199 in circulating exosomes from patients with OSCC and its role in the evaluation of relapse and prognosis in patients with OSCC. MATERIALS AND METHODS HUMAN SAMPLE

COLLECTION This study collected serum from 108 patients with OSCC and 50 healthy people from July 2014 to July 2019. All OSCC patients were confirmed by pathological diagnosis. Electronic

health records, lifestyle, biochemical characteristics, tumor staging, treatment interventions, relapses, and survival time were recorded for all subjects. This study was approved by the

ethics committee of the Third Xiangya Hospital, Central South University and in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The

written informed consents were obtained from all subjects. EXOSOMES ISOLATION The collected serum was centrifuged at 3,000×_g_ for 15 min at 4 °C. The supernatant was filtered through a 0.22

 μm filter, and exosomes were extracted using the ExoEasy Maxi Kit (cat no. 76064, Qiagen) according to the manufacturer’ instructions. The BCA kit (Thermo, USA) was used to quantify the

exosome protein concentration, and the samples were aliquoted (100 μL each sample) and stored at – 80 °C. EXOSOMES IDENTIFICATION TRANSMISSION ELECTRON MICROSCOPY 5 μL of the exosome sample

suspension was added to the Formvar-carbon copper mesh, and the exosome sample was stained with 3% phosphotungstic acid after being slightly dried. Exosomes were observed with a transmission

electron microscope at 80 kV and electron micrographs were taken at 50,000×. EXOSOME PARTICLE SIZE ANALYSIS The exosomes were resuspended in 50 μl of 1× PBS. The exosome particle size

distribution was analyzed using ZetaView (Particle Metrix, Germany) according to the manufacturer's instructions. THE MARKERS OF EXOSOMES An Exosome Protein Extraction Kit (cat no.

EZB-exo-PRO1, EZBioscience, Roseville, CA, USA) was used for protein extraction from exosomes according to the manufacturer recommended protocol. The proteins (20 μg) were separated on 12%

SDSPAGE and transferred to a polyvinylidene fluoride (PVDF) membrane. The membranes were blocked with 5% skimmed milk at room temperature for 2 h. The membranes were then incubated with

monoclonal primary antibody CD63 (1:1,000, Abcam) and TSG101 (1:1,000, Abcam), overnight at 4 °C. After washing 3 times with TBST, the membranes were incubated with secondary antibody goat

anti-rabbit IgG antibody (1:2,000) for 2 h. The bands were developed with Immobilon Western HRP substrate (Millipore, USA). The original blots were presented in Supplementary Fig. 2. CELL

CULTURE OSCC cell lines (SCC4, SCC9, SCC25, HN12, CAL27) and human oral keratinocyte cells (HOK) were purchased from the American Type Culture Collection (ATCC, Manassas, VA), and cultured

in 37 °C incubator with 95% humidity and 5% CO2 concentration. The medium was changed every 2 days, and passaged every 4 days. VIRAL CONSTRUCTIONS AND INFECTION The circ_0000199 vector was

synthesized by Invitrogen Co., Ltd. circ_0000199 sequence was inserted into pcDNA3.1. Circ_0000199 without the downstream reverse sequence was used as a negative control. Circ_0000199 vector

was finally cloned into the Tet-On Advanced Inducible Gene Expression System (Clontech Laboratories, Inc. Mountain View, CA, USA) according to the manufacturer's protocol. The target

sequence of circ_0000199 small interfering RNA (siRNA) was 5′-TACTATTTTTCGACAAAAAGGTAAACAGC-3′. These adenoviruses were constructed using the AAVPrime AAV System (GeneCopoeia, Inc.)

according to the manufacturer's protocol. SCC9 and HN12 were infected with viral at multiplicity of infection = 50 for 48 h. QUANTITATIVE POLYMERASE CHAIN REACTION (QPCR) QPCR was

performed as previously described14. Total RNA was extracted from exosomes using Plasma/Serum Exosome Purification and RNA Isolation Mini Kit (cat no. 58300, Thorold, Canada) following the

manufacturer recommended protocol. TaqMan Advanced miRNA assays (cat no. A25576, ThermoFisher, Shanghai, China) were used for detection of the expression of miRNAs following the manufacturer

recommended protocol. SYBR Premix EX Taq II (TaKaRa) was used for detection of the expression of circRNA and mRNA by real-time quantitative PCR on ABI 7500 Real-Time PCR System (SeqGen,

Inc., Torrance, CA). The primers were used as: circ_0000199, forward: 5′-CATTGCTTTCAGGGCTCTTGA-3′, reverse 5′-CCGCTCTCTCGACAAATGGA-3′; cytoplasmic polyadenylation element binding proteins

(CPEB) 3, forward: 5′-TTTGCCAGAGCGGTCACATA-3′, reverse 5′-GTGCGGGAAGTTCTGGAAGA-3′; poly (A) nuclease 2 (PAN2), forward: 5′-CGCCCCAATTGTGGGTAACT-3′, reverse 5′- TTCAGGTGGGCATCCAAGAC-3′; ,

ring finger protein, LIM domain interacting (RLIM), forward: 5′-ACCCTAAAACCTAGTATTTTCCACT-3′, reverse 5′-AACGTCTTGCAGATGGCTCA-3′; , neurite extension and migration factor (NEXMIF), forward:

5′-TGTATCCAACATGGTGGCCC-3′, reverse 5′-TTGTGGACCTGTTCTCGCTC-3′; cofilin 2 (CFL2), forward: 5′-TGAGGCCGCCATTTTAACCT-3′, reverse 5′- CCAAGTGTCGAACGGTCCTT-3′; phosphatase and actin regulator 2

(PHACTR2), forward: 5′-GGACATGAACGCCTGGAAGT-3′, reverse 5′-CTTTCGGAGGCACAGGTGAT-3′; GAPDH, forward: 3′-GAAAGCCTGCCGGTGACTAA-5′, reverse 3′-TTCCCGTTCTCAGCCTTGAC-5′. GAPDH was used as an

internal control. CELL VIABILITY ASSAY The cell viability was assessed by Cell Counting Kit-8 assay (cat no., B34304; Bimake, Shanghai, China) as previously described15. Briefly, SCC9 and

HN12 cells were infected with circ_0000199 siRNA or circ_0000199 expressed adenoviruses for 48 h at 37 °C with 5% CO2, and then were plated in 96-well plates at a density of 1,000 cells in

100 μl of the aforementioned DMEM + FBS media per well. Ten μl of CCK8 reagent was added into each well and incubated for 1 h at 37 °C with 5% CO2. Absorbance at 450 nm was measured using

the PARADIGM Detection Platform (Beckman Coulter, Inc., Brea, CA, USA). TERMINAL DEOXYNUCLEOTIDYL-TRANSFERASE-MEDIATED DUTP NICK END LABELLING (TUNEL) ASSAY Apoptotic cells were analyzed

using the TUNEL Chromogenic Apoptosis Detection kit (GeneCopoeia, Inc.) following the manufacturer recommended protocol. BIOINFORMATIC ANALYSIS Potential miRNA binding sites within

circ_0000199 were predicted by miRNA target prediction software based on RNAhybrid and miRanda as previously described16. The potential targets of miR-145-5p and miR-29b-3p were predicted by

miRwalk as previously described17. The structure of the miRNAs and target genes network were constructed using Cytoscape. STATISTICAL ANALYSIS All experiments were repeated at least three

times, and data were expressed as the mean ± standard error of the mean. Graphpad prism software (version 8, GraphPad Software, Inc., San Diego, CA, USA) was used to perform statistical

analysis. Differences between two groups were compared by student _t_-test. Differences among three or more groups were compared by one-way analysis of variance with a post hoc Bonferroni

test. χ2 test was used to analyze categorical variables. Kaplan–Meier method was used to analyze the overall survival rate and relapse rate. P < 0.05 was considered to indicate a

statistically significant difference. RESULTS THE EXPRESSION OF CIRC_0000199 IN CIRCULATING EXOSOMES OF PATIENTS WITH OSCC In this study, we isolated and purified circulating exosomes from

108 OSCC patients. The morphology of exosomes was identified by transmission electron microscopy (Fig. 1a). The size of particles was about 100 nm with concentration of 1.2 × 107

particles/ml (Fig. 1b). These particles expressed the markers of exosomes TSG101 and CD63 (Fig. 1c), suggesting that we obtained the circulating exosomes from serum. Compared with the

healthy subjects, the level of circ_0000199 in circulating exosomes from patients with OSCC was significantly increased (P < 0.001) (Fig. 2a), of which 68 cases with high expression of

circ_0000199, and the other 40 cases with low expression of circ_0000199 compared with the mean in heathy subjects (Table 1). In OSCC patients, the level of circ_0000199 in the patients at

III-IV TNM stage was significantly higher than in the patients with I–II TNM stage (P < 0.001) (Fig. 2b). We further analyzed the correlation between the level of circ_0000199 and the

clinical characteristics of patients with OSCC. As shown in Table 1, the expression of circ_0000199 in circulating exosomes was significantly associated with betel quid chewing (P  = 

0.0002), tumor size (P  = 0.0010), lymphatic metastasis (p = 0.0295), and TNM stage (P  = 0.0298). The expression of circ_0000199 in exosomes was not associated with gender, age, BMI,

smoking, and tumor differentiation (Table 1). ASSOCIATION BETWEEN EXPRESSION OF EXOSOMAL CIRC_0000199 AND SURVIVAL OUTCOME IN PATIENTS WITH OSCC In addition, we found that OSCC patients with

high exosomal circ_0000199 had lower overall survival (P < 0.0001) and disease-free survival rate (P < 0.0001) than the patients with low exosomal circ_0000199 (Fig. 2c,d). Univariate

and multivariate Cox regression analysis found that exosomal circ_0000199 was an independent factor affecting the survival of OSCC patients (HR, 3.57; 95% CI 2.48–6.24, P = 0.0035) (Tables

2, 3). In addition, the patients with high exosomal circ_0000199 had higher tumor recurrence rate (HR, 3.36; 95% CI 2.12–5.26, P = 0.0042) and higher mortality rate (HR, 4.31; 95% CI

2.57–7.28, P = 0.0027) than the patients with low exosomal circ_0000199 (Table 4). BIOLOGICAL FUNCTION OF CIRC_0000199 IN OSCC CELLS To further study the role of circ_0000199 in OSCC cells,

we tested the expression of circ_0000199 in different OSCC cell lines. Compared with HOK cells, the expression of circ_0000199 in OSCC cells was significantly increased, with the highest

expression in HN12 and the relative lower expression in SCC9 cells (Fig. 3a). We selected SCC9 and HN12 cells for further analysis. Circ_0000199 was overexpressed in SCC9 cells, and knocked

down in HN12 cells (Fig. 3b,c). The effects of circ_0000199 on the proliferation and apoptosis of OSCC cells were studied by CCK8 and Tunel staining. The results showed that overexpression

of circ_0000199 in SCC9 cells significantly promoted cell proliferation and reduced the number of TUNEL-positive cells (Fig. 3d,e); while knockdown of circ_0000199 in HN12 cells

significantly inhibited cell proliferation and increased the number of TUNEL-positive cells (Fig. 3f,g). We further studied the mechanism of circ_0000199. Bioinformatics analysis revealed

that circ_0000199 could interact with miR-145-5p and miR-29b-3p simultaneously (Fig. 4a). We also found that compared with HOK cells, the expression of miR-145-5p in OSCC cells was

significantly decreased, with the lowest expression in HN12 and the relative higher expression in SCC9 cells; similar results were also observed in the expression of miR-29b-3p

(supplementary Fig. 1a). In addition, the prediction of downstream target genes for miR-145-5p and miR-29b-3p revealed 5 common target genes (including CPEB3, PAN2, RLIM, NEXMIF, CFL2, and

PHACTR2) (Fig. 4b). We then examined the expression of these target genes after overexpression or knockdown of circ_0000199 in SCC9 and HN12 cells, respectively. We found that overexpression

of circ_0000199 significantly increased the expression of CPEB3, PAN2, RLIM and CFL2 in SCC9 cells, while knockdown of circ_0000199 significantly inhibited the expression of CPEB3, PAN2,

RLIM and CFL2 in HN12 cells (supplementary Fig. 1b). However, overexpression and knockdown of circ_0000199 did not significantly alter the expression of NEXMIF and PHACTR2 in SCC9 and HN12

cells (supplementary Fig. 1b). These target genes together affected a variety of biology processes, cellular component and molecular functions (Fig. 4c). KEGG database was used to analyze

the pathways that were enriched by these target genes18. The results showed that ECM-receptor interaction and TGF-beta signaling pathway may be the pathways with the greatest enrichment

(Fig. 4d). DISCUSSION Oral squamous cell carcinoma is a common head and neck tumor. Early surgery or radiotherapy can achieve good results, but most patients with head and neck squamous cell

carcinoma have exhibited cervical lymph node metastasis or distant metastasis at the first diagnosis. Although surgery plus radiotherapy or chemotherapy can delay the progression of the

disease, the patients with stage III/IV do not be improved the long-term survival rate19. Therefore, early diagnosis and early treatment are the key to the treatment of OSCC. Recent studies

have found that circulating exosomes in oral cancer patients are significantly higher than healthy people, which may be involved in the occurrence and development of oral cancer20. Exosomes

contain proteins, nucleic acids, and lipids. By passing these connotative substances between cells, exosomes can regulate immune function and promote tumor angiogenesis and metastasis, even

directly affect tumor cell growth21,22. CircRNAs are often enriched in exosomes and have high stability and tissue specificity. Therefore, exosomal circRNAs may be useful markers for

diagnosis and treatment of OSCC. In this study, circulating exosomal circ_0000199 was significantly increased in patients with OSCC and increased with the TNM stage. In addition, high

expression of circ_0000199 was associated with betel quid chewing, tumor size, and lymph node metastasis, suggesting its potential clinical application as an independent factor for

predicting survival and disease recurrence of OSCC patients. The epidemiological studies have showed that betel quid chewing is closely related to the occurrence of OSCC23. In 2003, the

World Health Organization identified betel nut as a primary carcinogen. Areca nut contains various alkaloids, including arecoline (ARC), arecaidine, and guvacoline. Among them, ARC has the

closest relationship with OSCC. ARC has cytotoxic effects on oral mucosal fibroblasts, can promote cell proliferation, induce collagen synthesis, cause collagen accumulation and induce oral

submucous fibrosis, and further accumulation may lead to the occurrence of OSCC24. By gain- and loss-functional experiments, we further found that overexpression of circ_0000199 was able to

promote cell proliferation and inhibit apoptosis, while knockdown of circ_0000199 exhibited opposite effects. Previous studies have shown that circRNAs, as a new type of competitive

endogenous RNA (ceRNA), act as miRNA sponge by which interact with miRNA to cause dysregulated expression of miRNA target genes, thereby participating in OSCC process25,26. In this study,

bioinformatics software predicted that circ_0000199 could interact with miR-145-5p and miR-29b-3p, which were downregulated in OSCC cells. MiR-145 and miR-29 are both tumor suppressor genes

in OSCC. Shao et al. found that miR-145 inhibited the growth of OSCC cells by targeting c-Myc and CDK627, while miR-29-3p was also a predicted target of circ_0072387 in oral squamous cell

carcinoma cells28. Further analysis revealed that miR-145-5p and miR-29b-3p could jointly target CPEB3, PAN2, RLIM, NEXMIF, CFL2 and PHACTR2. In addition, circ_0000199 could positively

regulated the expression of CPEB3, PAN2, RLIM and CFL2 in OSCC cells. Studies have showed that aberrant expression of these proteins correlates with certain types of cancer. CPEBs are

associated with specific sequences in mRNA 3 'untranslated regions to promote translation. Several CPEBs govern cell cycle progression, regulate senescence, establish cell polarity, and

promote tumorigenesis and metastasis29. PAN2 is an important regulator of the HIF1A-mediated hypoxic response30. RLIM knockdown significantly inhibits the proliferative and migratory

capacities of prostate cancer cells31. High CFL2 expression is associated with poor overall survival in gastric cancer32. Therefore, miR-145-5p and miR-29b-3p play an important role in

tumorigenesis and development of OSCC. Through analysis of the functions and signaling pathways of downstream molecules, we found that circ_0000199 had the greatest effect on cell surface

receptor signaling pathway in biology process, extra cellular space in cellular components, and transmembrane receptor protein kinase in molecular functions. In addition, the major

downstream signaling pathways regulated by circ_0000199 were ECM-receptor interaction, TGF-beta signaling pathway and MAPK signaling pathway. These signaling pathways have important effects

on the proliferation and apoptosis of OSCC cells33,34, suggesting that circ_0000199 regulates these signaling pathways via direct or indirect manner, and ultimately affects the progress of

OSCC, but the specific regulatory molecular mechanism still needs more experiments to illustrate. In summary, circulating exosomal circ_0000199 is highly expressed in patients with OSCC and

acts as an independent predictor for survival and disease recurrence in patients with OSCC. In addition, circ_0000199 is an oncogene in OSCC cells. These findings suggest that circulating

exosomal circ_0000199 can be used as biomarker and potential therapeutic target for OSCC. However, more studies, with more patients are need to confirm these findings. DATA AVAILABILITY All

data generated or analysed during this study are included in this published article. REFERENCES * Cramer, J. D., Burtness, B. & Ferris, R. L. Immunotherapy for head and neck cancer:

Recent advances and future directions. _Oral Oncol._99, 104460 (2019). Article  CAS  Google Scholar  * Economopoulou, P., de Bree, R., Kotsantis, I. & Psyrri, A. Diagnostic tumor markers

in head and neck squamous cell carcinoma (HNSCC) in the clinical setting. _Front. Oncol._9, 827 (2019). Article  Google Scholar  * Principe, S. _et al._ Tumor-derived exosomes and

microvesicles in head and neck cancer: Implications for tumor biology and biomarker discovery. _Proteomics_13, 1608–1623 (2013). Article  CAS  Google Scholar  * Economopoulou, P., Kotsantis,

I., Kyrodimos, E., Lianidou, E. S. & Psyrri, A. Liquid biopsy: An emerging prognostic and predictive tool in head and neck squamous cell carcinoma (HNSCC). Focus On circulating tumor

cells (CTCS). _Oral Oncol._74, 83–89 (2017). Article  CAS  Google Scholar  * Yin, Y. _et al._ Emerging roles of circRNA in formation and progression of cancer. _J. Cancer._10, 5015–5021

(2019). Article  CAS  Google Scholar  * Deng, W. _et al._ Microarray profile of circular RNAs identifies hsa_circRNA_102459 and hsa_circRNA_043621 as important regulators in oral squamous

cell carcinoma. _Oncol. Rep._42, 2738–2749 (2019). CAS  PubMed  Google Scholar  * Geng, Y., Jiang, J. & Wu, C. Function and clinical significance of circRNAs in solid tumors. _J. Hematol

Oncol._11, 98 (2018). Article  Google Scholar  * Chen, X. _et al._ Circle Rna hsa_circrna_100290 serves as a ceRNA for Mir-378a to regulate oral squamous cell carcinoma cells growth via

glucose transporter-1 (GLUT1) and glycolysis. _J. Cell Physiol._234, 19130–19140 (2019). Article  CAS  Google Scholar  * Wang, L. _et al._ Circdock1 suppresses cell apoptosis via inhibition

of mir196a5P by targeting BIRC3 in Oscc. _Oncol Rep._39, 951–966 (2018). CAS  PubMed  Google Scholar  * Xiao, C. _et al._ Exosomes in head and neck squamous cell carcinoma. _Front. Oncol._9,

894 (2019). Article  Google Scholar  * Huang, X. _et al._ Circular RNA Akt3 upregulates Pik3R1 to enhance cisplatin resistance in gastric cancer via mir-198 Suppression. _Mol. Cancer._18,

71 (2019). Article  Google Scholar  * Xia, X. _et al._ A novel tumor suppressor protein encoded by circular Akt3 RNA inhibits glioblastoma tumorigenicity by competing with active

phosphoinositide-dependent kinase-1. _Mol. Cancer._18, 131 (2019). Article  Google Scholar  * Xue, D. _et al._ Circ-Akt3 inhibits clear cell renal cell carcinoma metastasis via altering

mir-296-3P/E-cadherin signals. _Mol. Cancer._18, 151 (2019). Article  Google Scholar  * Fu, Y. _et al._ Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript

is an oncogene in multiple myeloma that suppresses mir-29B. _Cell Death Dis._10, 319 (2019). Article  Google Scholar  * Ma, J. _et al._ Bromodomaincontaining protein 7 sensitizes breast

cancer cells to paclitaxel by activating Bcl2antagonist/killer protein. _Oncol Rep._41, 1487–1496 (2019). CAS  PubMed  Google Scholar  * Kruger, J. & Rehmsmeier, M. Rnahybrid: MicroRNA

target prediction easy, fast and flexible. _ Nucleic Acids Res._34, W451–W454 (2006). Article  Google Scholar  * Sticht, C., De La Torre, C., Parveen, A. & Gretz, N. Mirwalk: An online

resource for prediction of microRNA binding sites. _PLoS ONE_13, e206239 (2018). Article  Google Scholar  * Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes.

_Nucleic Acids Res._28, 27–30 (2000). Article  CAS  Google Scholar  * Watters, A. L., Cope, S., Keller, M. N., Padilla, M. & Enciso, R. Prevalence of trismus in patients with head and

neck cancer: A systematic review with meta-analysis. _Head Neck._41, 3408–3421 (2019). Article  Google Scholar  * Lousada-Fernandez, F. _et al._ Liquid biopsy in oral cancer. _Int. J. Mol.

Sci._19, 1704 (2018). Article  Google Scholar  * Chen, G. _et al._ Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. _Nature_560, 382–386 (2018).

Article  ADS  CAS  Google Scholar  * Li, L. _et al._ Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver mir-21 to normoxic cells to elicit a prometastatic phenotype.

_Cancer Res._76, 1770–1780 (2016). Article  CAS  Google Scholar  * Wang, T. H., Hsia, S. M., Shih, Y. H. & Shieh, T. M. Association of smoking, alcohol use, and betel quid chewing with

epigenetic aberrations in cancers. _Int. J. Mol. Sci._18, 1210 (2017). Article  Google Scholar  * Khan, S., Chatra, L., Prashanth, S. K., Veena, K. M. & Rao, P. K. Pathogenesis of oral

submucous fibrosis. _J. Cancer Res. Ther._8, 199–203 (2012). Article  Google Scholar  * Bai, H., Lei, K., Huang, F., Jiang, Z. & Zhou, X. Exo-circRNAs: A new paradigm for anticancer

therapy. _Mol. Cancer._18, 56 (2019). Article  Google Scholar  * Zhao, W. _et al._ Splicing factor derived circular RNA circUHRF1 accelerates oral squamous cell carcinoma tumorigenesis via

feedback loop. _Cell Death Differ._27, 919–933 (2020). Article  CAS  Google Scholar  * Shao, Y., Qu, Y., Dang, S., Yao, B. & Ji, M. Mir-145 inhibits oral squamous cell carcinoma (OSCC)

cell growth by targeting C-myc and Cdk6. _Cancer Cell Int._13, 51 (2013). Article  CAS  Google Scholar  * Dou, Z. _et al._ Decreased expression of hsa_circ_0072387 as a valuable predictor

for oral squamous cell carcinoma. _Oral Dis._25, 1302–1308 (2019). Article  Google Scholar  * D’Ambrogio, A., Nagaoka, K. & Richter, J. D. Translational control of cell growth and

malignancy by the CPEBs. _Nat. Rev. Cancer._13, 283–290 (2013). Article  CAS  Google Scholar  * Bett, J. S. _et al._ The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA

stability. _Biochem. J._451, 185–194 (2013). Article  CAS  Google Scholar  * Guo, B. H., Zhao, Q. & Li, H. Y. Tug1 promotes the development of prostate cancer by regulating RLIM. _Eur.

Rev. Med. Pharmacol. Sci._23, 1926–1933 (2019). PubMed  Google Scholar  * Bian, Y., Guo, J., Qiao, L. & Sun, X. Mir-3189-3P mimics enhance the effects of S100A4 siRNA on the inhibition

of proliferation and migration of gastric cancer cells by targeting CFL2. _Int. J. Mol. Sci._19, 236 (2018). Article  Google Scholar  * Li, S. _et al._ Complex integrated analysis of

lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma. _Oral Oncol._73, 1–9 (2017). Article  Google Scholar  * Smith, A., Teknos, T. N. & Pan, Q. Epithelial to mesenchymal transition in

head and neck squamous cell carcinoma. _Oral Oncol._49, 287–292 (2013). Article  Google Scholar  Download references ACKNOWLEDGEMENTS This work was supported by National Natural Science

Foundation of China (No. 81573091 and No. 81802668) and Natural Science Foundation of Hunan Province (No. 2018JJ3776 and No. 2017JJ3467). AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *

Department of Blood Transfusion, The Third Xiangya Hospital of Central South University, Tongzipo Road 138, Changsha, 410013, Hunan, China Yanwei Luo, Fengxia Liu & Rong Gui * National

Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha, 410008, Hunan, P.R. China Jie Guo Authors * Yanwei Luo View author publications You

can also search for this author inPubMed Google Scholar * Fengxia Liu View author publications You can also search for this author inPubMed Google Scholar * Jie Guo View author publications

You can also search for this author inPubMed Google Scholar * Rong Gui View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS Y.L., F.L., J.G.,

and R.G. contributed to the study conception and design. Material preparation, data collection and analysis were performed by Y.L., F.L., J.G., and R.G.. The first draft of the manuscript

was written by Y.L.. Y.L., F.L., J.G., and R.G. commented on previous versions of the manuscript. Y.L., F.L., J.G., and R.G. read and approved the final manuscript. CORRESPONDING AUTHORS

Correspondence to Jie Guo or Rong Gui. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION PUBLISHER'S NOTE Springer Nature

remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION 1. RIGHTS AND PERMISSIONS OPEN

ACCESS This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format,

as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third

party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the

article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the

copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Luo, Y., Liu, F., Guo, J.

_et al._ Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC. _Sci Rep_ 10, 13739 (2020). https://doi.org/10.1038/s41598-020-70747-y Download

citation * Received: 05 February 2020 * Accepted: 03 August 2020 * Published: 13 August 2020 * DOI: https://doi.org/10.1038/s41598-020-70747-y SHARE THIS ARTICLE Anyone you share the

following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer

Nature SharedIt content-sharing initiative